Curaleaf Holdings, Inc. (TSE:CURA): Are Analysts Optimistic?

We feel now is a pretty good time to analyse Curaleaf Holdings, Inc.'s (TSE:CURA) business as it appears the company may be on the cusp of a considerable accomplishment. Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. On 31 December 2024, the CA$847m market-cap company posted a loss of US$232m for its most recent financial year. As path to profitability is the topic on Curaleaf Holdings' investors mind, we've decided to gauge market sentiment. We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

Curaleaf Holdings is bordering on breakeven, according to the 10 Canadian Pharmaceuticals analysts. They expect the company to post a final loss in 2026, before turning a profit of US$70m in 2027. The company is therefore projected to breakeven around 2 years from today. How fast will the company have to grow each year in order to reach the breakeven point by 2027? Working backwards from analyst estimates, it turns out that they expect the company to grow 59% year-on-year, on average, which is rather optimistic! Should the business grow at a slower rate, it will become profitable at a later date than expected.

We're not going to go through company-specific developments for Curaleaf Holdings given that this is a high-level summary, though, take into account that generally a pharma company has lumpy cash flows which are contingent on the drug and stage of product development the business is in. This means, large upcoming growth rates are not abnormal as the company is beginning to reap the benefits of earlier investments.

Check out our latest analysis for Curaleaf Holdings

Before we wrap up, there’s one issue worth mentioning. Curaleaf Holdings currently has a relatively high level of debt. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, which in Curaleaf Holdings' case is 57%. Note that a higher debt obligation increases the risk around investing in the loss-making company.

Next Steps:

There are key fundamentals of Curaleaf Holdings which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Curaleaf Holdings, take a look at Curaleaf Holdings' company page on Simply Wall St. We've also put together a list of essential aspects you should further examine:

1. Valuation: What is Curaleaf Holdings worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Curaleaf Holdings is currently mispriced by the market.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Curaleaf Holdings’s board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.